SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-003139
Filing Date
2021-05-04
Accepted
2021-05-04 16:34:21
Documents
1
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4188
  Complete submission text file 0001562180-21-003139.txt   5669
Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139
Business Address
Donovan Joanne M. (Reporting) CIK: 0001644087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 21889082

Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022 212-739-6451
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations